Search Results

There are 1827 results for: content related to: Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process?

  1. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6

    Clinical & Experimental Allergy

    Volume 45, Issue 5, May 2015, Pages: 928–939, L. Orivuori, K. Mustonen, M. C. de Goffau, S. Hakala, M. Paasela, C. Roduit, J.-C. Dalphin, J. Genuneit, R. Lauener, J. Riedler, J. Weber, E. von Mutius, J. Pekkanen, H. J. M. Harmsen, O. Vaarala and the PASTURE Study Group

    Version of Record online : 16 APR 2015, DOI: 10.1111/cea.12522

  2. You have free access to this content
    Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis

    Journal of Internal Medicine

    Volume 270, Issue 1, July 2011, Pages: 50–57, K. Andréasson, A. Scheja, T. Saxne, B. Ohlsson and R. Hesselstrand

    Version of Record online : 9 JAN 2011, DOI: 10.1111/j.1365-2796.2010.02340.x

  3. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2218–2224, Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen and Paul Rutgeerts

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22917

  4. Plasma Calprotectin Predicts Mortality in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

    Journal of Interventional Cardiology


    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1540-8183.2010.00532.x

  5. Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren’s syndrome but decreased by HIV infection

    Oral Microbiology and Immunology

    Volume 16, Issue 2, April 2001, Pages: 119–123, S. P. Sweet, A. N. Denbury and S. J. Challacombe

    Version of Record online : 21 DEC 2001, DOI: 10.1034/j.1399-302x.2001.016002119.x

  6. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 12, Issue 6, June 2006, Pages: 524–534, Michael R. Konikoff and Lee A. Denson

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200606000-00013

  7. You have free access to this content
    Calprotectin is released from human skeletal muscle tissue during exercise

    The Journal of Physiology

    Volume 586, Issue 14, July 2008, Pages: 3551–3562, Ole Hartvig Mortensen, Kasper Andersen, Christian Fischer, Anders Rinnov Nielsen, Søren Nielsen, Thorbjörn Åkerström, Maj-brit Aastrøm, Rehannah Borup and Bente Klarlund Pedersen

    Version of Record online : 14 JUL 2008, DOI: 10.1113/jphysiol.2008.153551

  8. Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis

    Journal of Periodontal Research

    Volume 46, Issue 4, August 2011, Pages: 417–426, D. Kaner, J.-P. Bernimoulin, T. Dietrich, B.-M. Kleber and A. Friedmann

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1600-0765.2011.01355.x

  9. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors

    Arthritis Care & Research

    Volume 68, Issue 7, July 2016, Pages: 899–906, José Inciarte-Mundo, Maria Victoria Hernández, Virginia Ruiz-Esquide, Sonia Raquel Cabrera-Villalba, Julio Ramirez, Andrea Cuervo, Mariona Pascal, Jordi Yagüe, Juan D. Cañete and Raimon Sanmarti

    Version of Record online : 23 JUN 2016, DOI: 10.1002/acr.22795

  10. Plasma calprotectin: A new prognostic marker of survival in alcohol-induced cirrhosis


    Volume 21, Issue 4, April 1995, Pages: 979–985, Christian Homann, Peter Garred, Niels Graudal, Philip Hasselqvist, Michael Christiansen, Magne K. Fagerhol and Åge Christian Thomsen

    Version of Record online : 9 DEC 2005, DOI: 10.1002/hep.1840210415

  11. Induction of calprotectin release by Porphyromonasgingivalis lipopolysaccharide in human neutrophils

    Oral Microbiology and Immunology

    Volume 19, Issue 3, June 2004, Pages: 182–187, J. Kido, R. Kido, Suryono, M. Kataoka, M. K. Fagerhol and T. Nagata

    Version of Record online : 26 APR 2004, DOI: 10.1111/j.0902-0055.2004.00139.x

  12. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children

    Acta Paediatrica

    Volume 91, Issue 1, January 2002, Pages: 45–50, E Olafsdottir, L Aksnes, G Fluge and A Berstad

    Version of Record online : 2 JAN 2007, DOI: 10.1111/j.1651-2227.2002.tb01638.x

  13. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

    Inflammatory Bowel Diseases

    Volume 15, Issue 8, August 2009, Pages: 1190–1198, Javier P. Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, Carlos Taxonera, Isabel Vera, Adrian G. McNicholl, Alicia Algaba, Pilar López, Natalia López-Palacios, Marta Calvo, Yago González-Lama, Jose-Antonio Carneros, Marta Velasco and José Maté

    Version of Record online : 16 MAR 2009, DOI: 10.1002/ibd.20933

  14. Calprotectin levels in meconium

    Acta Paediatrica

    Volume 92, Issue 4, April 2003, Pages: 463–466, N Laforgia, ME Baldassarre, G Pontrelli, F Indrio, MA Altomare, G Di Bitonto and A Mautone

    Version of Record online : 2 JAN 2007, DOI: 10.1111/j.1651-2227.2003.tb00579.x

  15. You have free access to this content
    Emerging role of calprotectin in gastroenterology

    Journal of Gastroenterology and Hepatology

    Volume 18, Issue 7, July 2003, Pages: 756–762, ANDREW POULLIS, RUSSELL FOSTER, MICHAEL A MENDALL and MAGNE K FAGERHOL

    Version of Record online : 10 JUN 2003, DOI: 10.1046/j.1440-1746.2003.03014.x

  16. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2018–2025, Patrick F. van Rheenen

    Version of Record online : 24 JAN 2012, DOI: 10.1002/ibd.22896

  17. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: A clue to the increased risk of intestinal malignancy in adulthood?

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 5, May 2015, Pages: 866–871, Tamara Pang, Steven T Leach, Tamarah Katz, Adam Jaffe, Andrew S Day and Chee Y Ooi

    Version of Record online : 10 APR 2015, DOI: 10.1111/jgh.12842

  18. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

    Inflammatory Bowel Diseases

    Volume 14, Issue 3, March 2008, Pages: 359–366, Marc A. Sidler, Steven T. Leach and Andrew S. Day

    Version of Record online : 29 NOV 2007, DOI: 10.1002/ibd.20336

  19. Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial Peritonitis

    Journal of Clinical Laboratory Analysis

    Samuel Raimundo Fernandes, Patrícia Santos, Narcisa Fatela, Cilénia Baldaia, Rui Tato Marinho, Helena Proença, Fernando Ramalho and José Velosa

    Version of Record online : 17 MAY 2016, DOI: 10.1002/jcla.21994

  20. No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide

    Acta Paediatrica

    Volume 96, Issue 7, July 2007, Pages: 1076–1079, Elisabeth Fernell, Ulrika L Fagerberg and Per M Hellström

    Version of Record online : 27 APR 2007, DOI: 10.1111/j.1651-2227.2007.00298.x